Biotech Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Central Nervous System Disease
Study data from University of London, Imperial College update understanding of central nervous system disease
May 12th, 2008
According to recent research from London, the United Kingdom, "Cough, a reflex defense mechanism, is a common symptom of many airway inflammatory diseases." "At present there are no satisfactory treatments for cough that have an acceptable side effect profile. Recent data have described the inhibitory effect of selective cannabinoid CB, receptor agonists on sensory nerve activity in vitro and the cough reflex in a guinea pig model," wrote M.G. Belvisi and colleagues, University of London, Imperial College. The researchers concluded: "CB2 receptor expression is limited in the central nervous system (CNS) and hence the development of selective agonists...
Source: Biotech Business Week (2008-05-12)
|
